Search Orphan Drug Designations and Approvals
-
Generic Name: | recombinant human interleukin-10 fusion protein |
---|---|
Date Designated: | 11/08/2022 |
Orphan Designation: | Treatment of pouchitis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Applied Molecular Transport, Inc. 1 Tower Place, Suite 850 South San Francisco, California 94080 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-